The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance
Open accessAbstract
OBJECTIVE: The global epidemic of metabolic syndrome and its complications demands rapid evaluation of new and accessible interventions. Insulin resistance is the central biochemical disturbance in the metabolic syndrome. The citrus-derived flavonoid, naringenin, has lipid-lowering properties and inhibits VLDL secretion from cultured hepatocytes in a manner resembling insulin. We evaluated whether naringenin regulates lipoprotein production and insulin sensitivity in the context of insulin resistance in vivo. RESEARCH DESIGN AND METHODS: LDL receptor–null (Ldlr−/−) mice fed a high-fat (Western) diet (42% calories from fat and 0.05% cholesterol) become dyslipidemic, insulin and glucose intolerant, and obese. Four groups of mice (standard diet, Western, and Western plus 1% or 3% wt/wt naringenin) were fed ad libitum for 4 weeks. VLDL production and parameters of insulin and glucose tolerance were determined. RESULTS: We report that naringenin treatment of Ldlr−/− mice fed a Western diet corrected VLDL overproduction, ameliorated hepatic steatosis, and attenuated dyslipidemia without affecting caloric intake or fat absorption. Naringenin 1) increased hepatic fatty acid oxidation through a peroxisome proliferator–activated receptor (PPAR) γ coactivator 1α/PPARα-mediated transcription program; 2) prevented sterol regulatory element–binding protein 1c–mediated lipogenesis in both liver and muscle by reducing fasting hyperinsulinemia; 3) decreased hepatic cholesterol and cholesterol ester synthesis; 4) reduced both VLDL-derived and endogenously synthesized fatty acids, preventing muscle triglyceride accumulation; and 5) improved overall insulin sensitivity and glucose tolerance. CONCLUSIONS: Thus, naringenin, through its correction of many of the metabolic disturbances linked to insulin resistance, represents a promising therapeutic approach for metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130 · cited 2×
“Peroxisome prolifertor–activated receptor (PPAR) coactivator 1 (PGC1 ) activation can initiate mitochondrial biogenesis (28).”
BackgroundInsulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,333
Boden, G., & Shulman, G. I. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.3.x · Cited by 1,300
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951
SHIMOMURA, I. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00009-5 · Cited by 855
Etiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 1×
“Intramyocellular lipids are associated with insulin resistance in vivo (30).”
BackgroundFROM MICE TO MEN: Insights into the Insulin Resistance Syndromes
Biddinger, S. B., & Kahn, C. R. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040104.124723 · Cited by 706
Grefhorst, A., Elzinga, B. M., Voshol, P. J., Plo¨sch, T., Kok, T., Bloks, V. W., van der Sluijs, F. H., Havekes, L. M., Romijn, J. A., Verkade, H. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204887200 · Cited by 498
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469
Jung, U. J., Lee, M.-K., Park, Y. B., Kang, M. A., & Choi, M.-S. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.12.002 · Cited by 414
Pullinger, C. R., North, J. D., Teng, B. B., Rifici, V. A., Ronhild de Brito, A. E., & Scott, J. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38287-0 · Cited by 412
Dixon, J., & Ginsberg, H. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40744-8 · Cited by 368
Mechanisms of Hepatic Very Low Density Lipoprotein Overproduction in Insulin Resistance
Taghibiglou, C., Carpentier, A., Van Iderstine, S. C., Chen, B., Rudy, D., Aiton, A., Lewis, G. F., & Adeli, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8416 · Cited by 347
Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis
Semple, R. K., Sleigh, A., Murgatroyd, P. R., Adams, C. A., Bluck, L., Jackson, S., Vottero, A., Kanabar, D., Charlton-Menys, V., Durrington, P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37432 · Cited by 344
Lipid and lipoprotein dysregulation in insulin resistant states
Avramoglu, R. K., Basciano, H., & Adeli, K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.026 · Cited by 318
Kerouz, N. J., Hörsch, D., Pons, S., & Kahn, C. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119872 · Cited by 302
Dreyer, C., Keller, H., Mahfoudi, A., Laudet, V., Krey, G., & Wahli, W. (1993) · Biology of the Cell · doi:10.1016/s0248-4900(05)80176-5 · Cited by 284
Haidari, M., Leung, N., Mahbub, F., Uffelman, K. D., Kohen-Avramoglu, R., Lewis, G. F., & Adeli, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200544200 · Cited by 269
Wilcox, L. J., Borradaile, N. M., de Dreu, L. E., & Huff, M. W. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31634-5 · Cited by 254
Self-citationInsulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes
Björnholm, M., & Zierath, J. R. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330354 · Cited by 228
Lewis, G. F., & Steiner, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.4.390 · Cited by 226
Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion
Sparks, J. D., & Sparks, C. E. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90088-4 · Cited by 222
Stefanovic-Racic, M., Perdomo, G., Mantell, B. S., Sipula, I. J., Brown, N. F., & O'Doherty, R. M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00497.2007 · Cited by 192
Genetic determinants of the metabolic syndrome
Pollex, R. L., & Hegele, R. A. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0638 · Cited by 171
Self-citationMerat, S., Casanada, F., Sutphin, M., Palinski, W., & Reaven, P. D. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1223 · Cited by 160
Shulman, G. I. (2004) · Physiology · doi:10.1152/physiol.00007.2004 · Cited by 152
Choi, J. S., Yokozawa, T., & Oura, H. (1991) · Planta Medica · doi:10.1055/s-2006-960075 · Cited by 149
Borradaile, N. M., de Dreu, L. E., & Huff, M. W. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2554 · Cited by 134
Self-citationGuillet-Deniau, I., Mieulet, V., Lay, S. L., Achouri, Y., Carré, D., Girard, J. R., Foufelle, F., & Ferré, P. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1722 · Cited by 129
Lee, S., Park, Y. B., Bae, K., Bok, S., Kwon, Y., Lee, E. S., & Choi, M. (1999) · Annals of Nutrition and Metabolism · doi:10.1159/000012783 · Cited by 128
Phung, T. L., Roncone, A. M., Jensen, K. L. D. M., Sparks, C. E., & Sparks, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30693 · Cited by 122
Allister, E. M., Borradaile, N. M., Edwards, J. Y., & Huff, M. W. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1676 · Cited by 116
Self-citationThe molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin
Telford, D. E., Sutherland, B. G., Edwards, J. Y., Andrews, J. D., Barrett, P. H. R., & Huff, M. W. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600439-jlr200 · Cited by 111
Self-citationRegulation of Microsomal Triglyceride Transfer Protein Gene by Insulin in HepG2 Cells
Au, W.-S., Kung, H.-F., & Lin, M. C.-M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1073 · Cited by 108
Borradaile, N. M., de Dreu, L. E., Barrett, P. H. R., Behrsin, C. D., & Huff, M. W. (2003) · Biochemistry · doi:10.1021/bi026731o · Cited by 106
Self-citationWiegman, C., Bandsma, R., Ouwens, D. M., van der Sluijs, F. H., Havinga, R., Boer, T. S., Reijngoud, D., Romijn, J. A., & Kuipers, F. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1081 · Cited by 102
Xia, Z., Sniderman, A. D., & Cianflone, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207281200 · Cited by 98
Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice
Han, S., Liang, C.-P., Westerterp, M., Senokuchi, T., Welch, C. L., Wang, Q., Matsumoto, M., Accili, D., & Tall, A. R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36523 · Cited by 97
Srivastava, R. A. K., Jahagirdar, R., Azhar, S., Sharma, S., & Bisgaier, C. L. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9053-y · Cited by 95
Millar, J. S., Stone, S. J., Tietge, U. J. F., Tow, B., Billheimer, J. T., Wong, J. S., Hamilton, R. L., Farese, R. V., & Rader, D. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600213-jlr200 · Cited by 91
Chirieac, D. V., Chirieac, L. R., Corsetti, J. P., Cianci, J., Sparks, C. E., & Sparks, J. D. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1003 · Cited by 87
Inhibition of hepatocyte apoB secretion by naringenin
Borradaile, N. M., de Dreu, L. E., Barrett, P. H. R., & Huff, M. W. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200115-jlr200 · Cited by 79
Self-citationHuong, D. T. T., Takahashi, Y., & Ide, T. (2006) · Nutrition · doi:10.1016/j.nut.2005.11.006 · Cited by 68
Allister, E. M., Mulvihill, E. E., Barrett, P. H. R., Edwards, J. Y., Carter, L. P., & Huff, M. W. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800297-jlr200 · Cited by 49
Self-citationAcyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion
Burnett, J. R., Wilcox, L. J., & Huff, M. W. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00104-7 · Cited by 34
Self-citation
Cited by
Alam, M. A., Subhan, N., Rahman, M. M., Uddin, S. J., Reza, H. M., & Sarker, S. D. (2014) · Advances in Nutrition · doi:10.3945/an.113.005603 · Cited by 788
AL-Ishaq, R. K., Abotaleb, M., Kubatka, P., Kajo, K., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9090430 · Cited by 741
Antidiabetic Properties of Dietary Flavonoids: A Cellular Mechanism Review
Vinayagam, R., & Xu, B. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0057-7 · Cited by 597
He, B., Nohara, K., Park, N., Park, Y.-S., Guillory, B., Zhao, Z., Garcia, J. M., Koike, N., Lee, C. C., Takahashi, J. S., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.007 · Cited by 507
Beneficial effects of naringenin in liver diseases: Molecular mechanisms
Hernández-Aquino, E., & Muriel, P. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i16.1679 · Cited by 347
Metadata
- Authors
- Mulvihill, E. E., Allister, E. M., Sutherland, B. G., Telford, D. E., Sawyez, C. G., Edwards, J. Y., Markle, J. M., Hegele, R. A., & Huff, M. W.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-07-10
- Volume
- 58
- Issue
- 10
- Pages
- 2198-2210
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2149098343
- Cited by
- 297
- References
- 52
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.